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Glutathione Peroxidase Prevents the Inactivation of
Nitric Oxide and Restores the Inhibition of Platelet
Function by S-Nitrosothiols
JACC February 1995
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Expression of a Mutation Causing Hypertrophic
Cardiomyopathy Disrupts Sarcomere Assembly in
Adult Feline Cardiac Myocytes
Jane E. Freedman, Balz Frei, George N. Welch, Joseph Loscalzo. Boston University
School of Medicine, Boston, MA
The interaction of nitric oxide (NOI with reactive oxygen species in the
vasculature can inactivate NO leading to potentially adverse vascular con-
sequences. Glutathione peroxidases (GSH-Px). a family of antioxidant en-
zymes present at reduced concentrations in plasma and platelets of patients
with coronary artery disease, catalyze the reduction of hydrogen peroxide
and lipid hydroperoxides (LOOH) by glutathione. Given the role of LOOH in
platelet eicosanoid metabolism and their presence in atherosclerotic plaque,
we investigated the effect of GSH-Px on the inhibition of platelet function
by the naturally occurring NO donor, S-nitroso-glutathione (SNO-Glu). Sub-
threshold inhibitory concentrations of SNO-Glu were added to platelet-rich
plasma, and aggregation was induced by arachidonate. The addition of GSH-
Px (0.2-20 U/ml) to this system led to a dose-dependent inhibition of platelet
aggregation with an ICso = 0.6 U/ml GSH-Px (p < 0.05 by ANOVA). Super-
oxide dismutase (0.1-200 U/ml). catalase (0.1-200 U/ml), or GSH-Px without
SNO-Glu did not alter platelet aggregation responses. The addi ion of GSt-J-
Px to a subthreshold inhibitory concentration of sodium nitroprusside also
did not affect platelet aggregation responses. LOOH increased platelet ag-
gregation in the presence of SNO-Glu, an effect reversed by GSH-Px. Levels
of cGMP were measured after platelets were incubated with SNO-Glu, ex-
ogenous LOOH, and GSH-Px. SNO-Glu alone increased cGMP levels, and
this effect was attenuated by LOOH but restored by the addition of GSH-Px
GSH-Px activity was equivalent with either SNO-Glu or glutathione as cosub-
strate. Incubation of SNO-Glu with GSH-Px led to a 48.5% decrease in the
concentration of SNO-Glu as determined by HPLC-electrochemical detec-
tion. Incubation of SNO-Glu with albumin in the presence of GSH-Px led to
increased formation of S-nitroso-albumin, a prevalent reservoir of EDRF in
plasma. These results show that GSH-Px, at physiologically relevant concen-
trations, has a potent effect on NO-induced inhibition of platelet aggrega-
tion and that this enzyme may have two functions: (i) metabolism of LOOH,
thereby preventing its inactivation of NO; and Iii) metabolism of SNO-Glu,
thereby liberating NO and/or supporting further transnitrosation reactions
These findings suggest that GSH-Px, in addition to its antioxidant functions,
regulates the availability of NO in the vasculature and possibly alters platelet-
dependent thrombotic events.
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1407-41 Estradiol-17p Attenuates Directed Migration of
Vascular Smooth Muscle Cells
Frank D. Kolodgie, Anup Jacob, Renu Vlrmani, PatriCia S. Wilson, Greg C. Carlson,
Andrew Farb. Armed Forces Institute of Pathology, Washington, DC
Intimal proliferation and migration of smooth muscle cells are important
components of atherosclerotic progress·,on. Experimental studies suggest
an antiatherogenic property of 17p-estradiol (PE2) independent of its ef-
fects on serum lipids and lipoproteins. Although the beneficial effect af-
forded by PE2 is thought to be mediated in part by its antiproliferative
properties, its action on smooth muscle cell migration is unknown. To ex-
plore this relationship, female rat aortic smooth muscle cells IRASMC) were
grown in hormone-free medium and the effect of various concentrations
of pE2 on directed cellular migration was measured in-vitro using a micro-
well Boyden chamber apparatus. Immunocytochemistry demonstrated pos-
itive staining for estrogen receptors on RASMC. Migration of RASMC to the
known chemoattractants platelet-derived growth factor IPDGF-BB), insulin-
like growth factor-1, and fibronectin (all at maximal doses for migratory ac-
tivity) was attenuated by pE2 (0.1 to 10 ng/mll in a concentration-dependent
manner relative to control cells treated with vehicle 10.01 % ethanol). This ef-
fect was insensitive to pretreatment with indomethacin and stereospecific
because the enantiomer 17a-estradiol had no response. Like pE2, the syn-
thetic estrogen diethylstilbesterol attenuated directed RASMC chemotaxis
whereas testosterone was ineffective. Further studies showed that pE2-
mediated suppression of migration was inhibited by both the antiestrogen
ICI164,384 and the gene transcription inhibitor actinomycin D. Similarly, both
staurosporine and the more selective protein kinase C inhibitor GF 109203X
neutralized the inhibitory effects of pE2. [3H]Thymidine uptake in PDGF-BB
stimulated RASMC was not significantly affected by pE 2 in concentrations
up to 100 ng/ml thus, providing further in vitro evidence of the importance
of the effects of ,BE2 on smooth muscle cell migration. These are the first re-
sults demonstrating a reduction in directed smooth muscle cell chemotaxis
by PE2' The mechanism of this ,BE2-mediated response appears to involve
gene transcription and is sensitive to modulation by protein kinase C.
Ali J. Marian, Qun-Tao Yu, Douglas L. Mann, Frank L. Graham 1, Robert Roberts.
Baylor College of Medicine, Houston, Texas, USA; 1 McMaster University, Hamilton,
Ontario, Canada
Mutations in the p myosin heavy chain (,BMHC) gene cause hypertrophic
cardiomyopathy (HCM). a disease characterized by sudden death, cardiac
hypertrophy and sarcomere disarray. To determine the primary defect, we
sought to express a mutant pMHC gene in adult feline cardiac myocytes.
The feline model was selected since HCM is a common disease in cats with
a phenotype identical to that of man and the cardiac myosin is ,BMHC as in
man in contrasttoaMHC in the mouse. A full length human pMHC cDNAwas
cloned for the first time and an HCM causing mutation (Arg403 Gln) was in-
duced by site-directed mutagenesis. The adenoviral vector was selected for
its high efficiency of gene transfer and reconstructed to accommodate the 7
kb ,BMHC cDNA and promoter. The normal and mutant ,BMHC cDNAs were
cloned into a shuttle vector (ll.E1sp1 B) downstream to a cytomegalovirus
promoter and the 7 kb fragment was incorporated through homologous re-
combination during co-transfection of pll.E1 sp1 B/CMV/pMHC and pBHG1 0
in 293 host cells. Adult feline cardiac myocytes were transfected with the
recombinant viruses and examined at 48 and 120 hours after transfection.
Expression of the pMHC into mRNA was confirmed by RT-PCR. Net myosin
synthesis, determined by 3H phenylalanine incorporation (48 hr). was greater
in myocytes with normal or mutant pMHC constructs than control myocytes
or those infected with vector alone Ip < 0.05). Electron microscopy showed
normal sarcomere assembly at 48 hours in >90% of myocytes, however, at
120 hours sarcomere disruption was evident in >50% of myocytes infected
with mutant pMHC but remained intact in control myocytes and those in-
fected with normal ,BMHC or vector alone (p = 003). In this study, we suc-
cessfully incorporated a 7 kb pMHC/promoter construct into an adenoviral
vector and showed its expression in adult feline cardiac myocytes. The mu-
tant ,BMHC induced sarcomere and filament disarray similar to the lesion
seen in man. This would indicate sarcomere disarray is the primary defect in
HCM and the hypertrophy is compensatory.
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!407-Sllntraarterial Beta Irradiation Prevents Neointimal
Hyperplasia in a Hypercholesterolemic Rabbit
Restenosis Model
Vitali Verin, Youri POPOWSki, Philip Urban, Jacques Belenger, Mireille Redard,
Manuel Costa, Marie-Claude Widmer, Michael Schwager 1, John Kurtz,
Wilhelm Rutishauser. Cardiology Center and Division of Radiation Oncology. University
Hospital, Geneva, Switzerland,· 1 Schneider, Europe, AG
Intraarterial gamma irradiation reduces restenosis following balloon angio-
plasty. Beta irradiation has the advantages of a markedly steeper dose de-
crease in tissue and less radioprotection problems, permitting its use in
the setting of an ordinary catheterization laboratory. Flexible yttrium coils
(diameter 0.016", length 24 mm) were activated in a nuclear reactor. Use
of a segmented balloon consisting of four interconnected compartments
(*Schneider, Europe, AG) allowed for intraarterial centering of the 90Y source
and homogeneous intramural dose delivery. Under fluoroscopic guidance,
one carotid and one iliac artery of 21 hypercholesterolemic rabbits were
deendothelialized and then simultaneously dilated and irradiated. Four dose
schedules were studied: 1) controlldilated, non irradiated); 2) 6 Gray (Gy);
3) 12 Gy and 4) 18 Gy. Arterial specimens were histologicaly evaluated at 8
days and at 6 weeks. A minimum of 5 arteries were studied in each group at
each study end-point. There was a significant decrease (p < 0.001-0.05) in
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bromodeoxyuridine incorporation and in total neointimal cell number per cm
of inner arterial circumference for all radiation doses at 8 days compared to
control. At 6 weeks, histological computer derived % area stenosis and mean
number of neointimal cell layers were significantly reduced (p < 0.01, P <
0.005 respectively) in the group of arteries that had received 18 Gy compared
to the control group, but not in the 6 or 12 Gy groups (Graph). Conclusions:
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(l)lntraarterial beta irradiation is feasible; (2) Radiation doses between 6 and
18 Gy effectively inhibit neointimal smooth muscle cell proliferation at 8 days;
(3) This inhibitory effect is lost during the following post treatment weeks in
arteries having received radiation doses of 6 or 12 Gy; (4) A radiation dose
of 18 Gy effectively induces long-term inhibition of neointimal hyperplasia in
a hypercholesterolemic rabbit model of postangioplasty restenosis.
